BURLINGTON, Mass., May 7, 2024
/PRNewswire/ -- RxSugar® and SiPhox Health are
partnering to deliver solutions to combat the epidemic of
diet-related disease. These chronic diseases are the leading cause
of death and disability in the United
States, with 90% of the nation's $3.8
trillion in annual health care expenditures attributed to
people with chronic illness and mental health conditions (Centers
for Disease Control and Prevention (CDC)).
SiPhox Health is a well-recognized industry leader
in the development of home biomarker testing solutions. The SiPhox
vision is to enable affordable, convenient, and comprehensive
testing of biomarkers that will support the transformation of
healthcare from a reactive to a proactive mode.
RxSugar® stands at the forefront of scientific
innovation related to products derived from Allulose—a natural rare
sugar. Extensive research, including non-clinical and human
studies, substantiates Allulose's significant role in vital
physiological functions pertinent to cardiometabolic health
[references].
March 2024 saw the debut of the
SiPhox Heart Health Blueprint. Using the novel SiPhox mail-in home
blood testing kit, members can: 1) evaluate their cardiometabolic
disease risk; 2) receive a tailored plan that may include
medications or scientifically validated solutions; 3) fine-tune
outcomes. Members can access a protocol developed by the RxSugar®
and SiPhox Science Advisory teams to improve abnormal biomarkers
indicative of metabolic disease, leveraging RxSugar® products to
help individuals improve blood glucose control, insulin response
and satiety through naturally elevated GLP-1 levels.
Michael Dubrovsky, SiPhox
Co-Founder & Chief Product Officer: "Our goal is to not only
help Heart Health Blueprint members understand their health status
holistically but also to guide them in the direction of
evidence-based, scientifically proven, affordable tools to improve
their health. The compelling data that Allulose and RxSugar®
products can favorably elevate natural GLP-1 levels and modulate
insulin response made it clear to us that this was the type of
product that would be valuable to our users concerned about
cardiometabolic disease."
Neil Gyte, RxSugar® Chief
Business Officer: "The synergy between our two companies is
clear. We both believe that to truly help people live longer
healthier lives, we need to develop innovative and accessible
natural solutions that can be used safely, regardless of where an
individual is in their health journey. RxSugar® products are
formulated to help individuals in their quest to improve metabolic
health and we are excited about our strategic partnership with
SiPhox to support this wellness journey."
Dr. Ben Bikman, RxSugar®
Scientific Advisor: "Metabolic dysfunction and chronic inflammation
are pivotal drivers of chronic disease conditions including
cardiovascular disease, diabetes, cancer and neurodegenerative
disorders. The SiPhox platform allows members to routinely test a
wide array of traditional biomarkers providing a holistic snapshot
of their comprehensive health and risk of disease. Individuals
interested in using RxSugar® products to improve metabolic health
can now monitor the impact on key biomarkers and adjust accordingly
in order to optimize outcomes."
SiPhox Health is a Series A company in Boston backed by Khosla-ventures,
Y-Combinator, and Intel Capital with extensive leadership in
silicon photonics, optical chip technology, microfluidics, and
biochemistry. The SiPhox mission is to develop novel home lab
testing solutions that are comprehensive, convenient, and
affordable to enable proactive and personalized healthcare.
Currently, SiPhox has a marketed mail-in home blood test kit that
measures 17 biomarkers for inflammation, cardiovascular risk,
metabolic health, and hormonal balance. To learn more about the
Heart Health Blueprint, visit:
https://home.siphoxhealth.com/blueprints/heart-health.
Founded in 2019, RxSugar® is a health and wellness
company disguised as a food company. RxSugar® takes a
science driven approach to create innovative natural products that
support metabolic health – the primary root cause of all chronic
diseases. RxSugar's prime directive is to Solve For Sugar, the
leading driver of chronic illness. RxSugar® is Sugar
Reimagined®, the natural Allulose sugar that is
delicious, certified and fully functional. To learn more,
visit https://rxsugar.com/.
References:
- Jour. Func
Foods: https://www.sciencedirect.com/science/article/pii/S175646462300169X
- Nature
Comm: https://www.nature.com/articles/s41467-017-02488-y
- Cell Metab: https://pubmed.ncbi.nlm.nih.gov/32502381/
- J. Biol
Chem: https://pubmed.ncbi.nlm.nih.gov/23035112/
- Nature
Letters: https://www.nature.com/articles/s41586-018-0849-9
- Cell Metab: https://pubmed.ncbi.nlm.nih.gov/30943389
Media Contact:
Philip Yin, MD/PhD
Head of Clinical Product
781- 262-3683
377281@email4pr.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/rxsugar-and-siphox-health-partner-to-combat-the-epidemic-of-diet-related-disease-302137784.html
SOURCE SiPhox Health